Results 231 to 240 of about 7,388,180 (256)

Residual disease activity in cystic fibrosis lung disease: implications for clinical management and research. [PDF]

Am J Respir Crit Care Med
Gramegna A, Putti G, Alicandro G, Mall MA, Blasi F.   +4 more
europepmc   +1 more source

Correction to: First Genotype-Phenotype Study in TBX4 Syndrome: Gain-of-Function Mutations Causative for Lung Disease. [PDF]

Am J Respir Crit Care Med
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions

Ca-A Cancer Journal for Clinicians, 2023
Zsolt Megyesfalvi, Balázs Döme, Carl M Gay   +2 more
exaly  

Acquiring tissue for advanced lung cancer diagnosis and comprehensive biomarker testing: A National Lung Cancer Roundtable best-practice guide

Ca-A Cancer Journal for Clinicians, 2023
Raymond U Osarogiagbon, Farhood Farjah, Adam H Fox   +2 more
exaly  

Racial and socioeconomic disparities in lung cancer screening in the United States: A systematic review

Ca-A Cancer Journal for Clinicians, 2021
Dan J Raz, Loretta Erhunmwunsee, Virginia Chih-Yi Sun   +2 more
exaly  

An update on the immune landscape in lung and head and neck cancers

Ca-A Cancer Journal for Clinicians, 2020
Jennifer W Carlisle, Taofeek K. Owonikoko, Nabil F. Saba   +2 more
exaly